Champions Oncology (CSBR) Total Non-Current Liabilities (2011 - 2026)

Champions Oncology's Total Non-Current Liabilities history runs 16 years deep, the most recent figure standing at $24.0 million for Q1 2026.

• In Q1 2026, Total Non-Current Liabilities fell 3.34% year-over-year to $24.0 million; the TTM figure through Jan 2026 stood at $24.0 million (down 3.34% YoY), while the FY2025 annual figure was $28.5 million, up 3.09% from the prior year.
• Total Non-Current Liabilities was $24.0 million for Q1 2026 at Champions Oncology, down from $25.9 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $29.1 million in Q2 2023 to a low of $24.0 million in Q1 2026.
• Historically, Total Non-Current Liabilities has averaged $26.4 million across 5 years, with a median of $26.6 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Total Non-Current Liabilities soared 41.92% in 2022, then fell 12.59% in 2024.
• A 5-year view of Total Non-Current Liabilities shows it stood at $26.6 million in 2022, then climbed by 4.35% to $27.7 million in 2023, then retreated by 12.59% to $24.2 million in 2024, then gained by 6.81% to $25.9 million in 2025, then dropped by 7.12% to $24.0 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $24.0 million (Q1 2026), $25.9 million (Q4 2025), and $26.9 million (Q3 2025), per Business Quant data.